Ambu Nordic A/S: Financial statements 2020
CVR: 40311408
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
Ambu Nordic A/S (CVR 40311408) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,550 and a net result of DKK -1,209. Equity in the 2020 report amounted to DKK 375,191. The solvency ratio was 99.8%.
- Gross Profit
- DKK -1,550
- Profit/Loss
- DKK -1,209
- Equity
- DKK 375,191
- Total Assets
- DKK 375,891
Official annual report
How creditworthy is Ambu Nordic A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Ambu Nordic A/S has published its interim report for the period March 4, 2019 – September 30, 2019.
As of February 27, 2020, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Ambu Nordic A/S.
As of January 30, 2020, Camilla Præst Meister is registered as director of Ambu Nordic A/S.
As of January 30, 2020, Lars Nilaus Neuteboom Nielsen has stepped down as director of Ambu Nordic A/S.
About Ambu Nordic A/S
Ambu Nordic A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sjur Teksle Nøland. The board consists of Henrik Skak Bender (chair), Anita Krarup Frederiksen and Sjur Teksle Nøland. The company is owned by AMBU A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -725 and a net result of DKK 16,162 compared with DKK -2,020 the year before. Equity in the 2025 report amounted to DKK 387,315.